<- Go Home
Boule Diagnostics AB (publ)
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics companies. Boule Diagnostics AB (publ) was founded in 1956 and is headquartered in Spånga, Sweden.
Market Cap
SEK 423.3M
Volume
23.5K
Cash and Equivalents
SEK 40.9M
EBITDA
SEK 63.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
SEK 252.0M
Profit Margin
43.75%
52 Week High
SEK 12.62
52 Week Low
SEK 8.66
Dividend
N/A
Price / Book Value
0.85
Price / Earnings
15.79
Price / Tangible Book Value
1.04
Enterprise Value
SEK 560.8M
Enterprise Value / EBITDA
8.68
Operating Income
SEK 45.6M
Return on Equity
5.57%
Return on Assets
3.65
Cash and Short Term Investments
SEK 40.9M
Debt
SEK 178.4M
Equity
SEK 498.0M
Revenue
SEK 576.0M
Unlevered FCF
-SEK 9.4M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium